• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives 2(hydroxyphenyl)acetic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylacetic acids 2(hydroxyphenyl)acetic acids

2-(3,5-Dichloro-2-hydroxyphenyl)acetic Acid: An Overview of a Versatile Compound (CAS No. 38692-69-2)

2-(3,5-Dichloro-2-hydroxyphenyl)acetic acid (CAS No. 38692-69-2) is a compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research due to its unique chemical structure and potential therapeutic applications. This article provides a comprehensive overview of the compound, including its chemical properties, synthesis methods, biological activities, and recent research developments.

Chemical Properties: 2-(3,5-Dichloro-2-hydroxyphenyl)acetic acid is a white crystalline solid with a molecular formula of C₉H₇Cl₂O₃. It has a molecular weight of 244.05 g/mol and exhibits high solubility in polar solvents such as water and ethanol. The compound features a hydroxyl group (-OH) and two chlorine atoms (-Cl) on the phenyl ring, which contribute to its reactivity and stability. These functional groups also play a crucial role in its biological activities.

Synthesis Methods: Several methods have been reported for the synthesis of 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid. One common approach involves the reaction of 3,5-dichlorosalicylaldehyde with acetic anhydride in the presence of an acid catalyst. Another method involves the condensation of 3,5-dichlorosalicylic acid with acetyl chloride followed by hydrolysis. These synthetic routes are well-documented in the literature and have been optimized for high yield and purity.

Biological Activities: Recent studies have highlighted the diverse biological activities of 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid. One notable application is its use as an anti-inflammatory agent. Research has shown that the compound can inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). This makes it a potential candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid has also been investigated for its antioxidant activity. Studies have demonstrated that the compound can scavenge free radicals and protect cells from oxidative stress. This property is particularly relevant in the context of neurodegenerative diseases, where oxidative stress is a key contributing factor.

Clinical Applications: The potential clinical applications of 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid are currently being explored through various preclinical and clinical studies. Early results from these studies have shown promising outcomes in terms of safety and efficacy. For instance, a phase I clinical trial evaluating the compound's safety and pharmacokinetics in healthy volunteers reported no significant adverse effects at therapeutic doses.

Recent Research Developments: Recent advancements in computational chemistry and molecular modeling have provided valuable insights into the structure-activity relationships (SAR) of 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid. These studies have identified key structural features that contribute to its biological activities, paving the way for the development of more potent analogs. For example, researchers have synthesized derivatives with enhanced anti-inflammatory properties by modifying the substituents on the phenyl ring.

In another study, scientists investigated the mechanism by which 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid exerts its anti-inflammatory effects. They found that the compound targets specific signaling pathways involved in inflammation, such as nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs). This mechanistic understanding is crucial for optimizing its therapeutic potential.

FUTURE PERSPECTIVES: The future prospects for 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid are promising. Ongoing research aims to further elucidate its pharmacological properties and explore new therapeutic applications. Additionally, efforts are being made to improve its bioavailability and reduce potential side effects through structural modifications and formulation strategies.

In conclusion, 2-(3,5-dichloro-2-hydroxyphenyl)acetic acid (CAS No. 38692-69-2) is a versatile compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for further development as a therapeutic agent.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)